DRW Securities, LLC

Broker-Dealer

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1481986 CHICAGO, IL

Back to BMRN Full portfolio

Position in BMRN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$701,944

+$396,593 QoQ

Shares Held

12,426

+141.8% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Mar 31, 2024

CallValue

CallShares

PutValue

$864,666

PutShares

9,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DRW Securities, LLC holds $19,602,546 across 58 Biotechnology names. BMRN ranks #7 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	33,573	$1,350,641
2	PTCT	Ptc Therapeutics, Inc.	18,169	$1,237,853
3	KURA	Kura Oncology, Inc.	132,174	$1,074,574
4	FOLD	AMICUS THERAPEUTICS, INC.	70,670	$1,021,888
5	ARGX	Argenx SE	1,247	$910,621
6	MNKD	Mannkind Corp	305,121	$747,546
7	BMRN	Biomarin Pharmaceutical Inc This page	12,426	$701,944
8	INSM	INSMED Inc	3,698	$604,696

All Filings in BMRN

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$701,944	12,426	+141.8%	Shares	Other	2026-05-13
2025-12-31	$305,351	5,138	+3.2%	Shares	Other	2026-02-12
2025-09-30	$269,716	4,980	-28.2%	Shares	Other	2025-11-14
2025-06-30	$381,271	6,936	-6.3%	Shares	Other	2025-08-14
2024-03-31	$646,316	7,400	-25.3%	Shares	Other	2024-05-14
2024-03-31	$864,666	9,900	—	Put	Other	2024-05-14
No filing history on record for this holder in this stock.